{"nct_id":"NCT04102007","title":"A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab","status":"COMPLETED","status_verified_date":"2023-11","start_date":"2019-11-12","start_date_type":"ACTUAL","primary_completion_date":"2022-01-17","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}